Manejo intervencionista en estenosis de arterias renales y su impacto sobre el control de la presión arterial
Article Sidebar
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloads
Societal impact
Main Article Content
Abstract
Introduction: Renovascular hypertension is the second most frequent cause of secondary arterial hypertension, after parenchymal damage (or chronic kidney disease) which stands first. Nowadays, there is a lack of evidence to support therapeutic interventions that impact arterial pressure control in a positive way, or that help avoiding renal disease.
Methods: Observational retrospective studiy performed on patients undergoing angioplasty / stent management for angiographically significant renal stenosis. The effect of the intervention was indirectly evaluated by means of the change in the number of pills taken every day before and after the procedure.
Results: A total of 34 patients were included in this research, as it was observed that the median of the take of prior antihypertensive medicines to the procedure was 5,5 pills (IQR 3 - 18) and after the procedure was 5 pills (IQR 2.75 – 7.25), Z = -1.042 for p-value = 0,16.
Conclusion: No difference was found in the control of arterial pressure, measured by the reduction in the number of antihypertensives pills that patients take on a daily basis.
Article Details
References
Rao RK, Hood DB, Weaver FA. Current endovascular management of atherosclerotic renal artery stenosis. Surg Clin N Am. 2004;84(5):1353-1364.
Garovic V, Textor S. Renovascular hypertension and ischemic nephropathy. Circulation. 2005;112:1362- 1374.
Safian R, Textor S. Renal-artery stenosis. N Engl J Med. 2001;344:431-42.
Cheung CM, Hegarty J, Kalra PA. Dilemmas in the management of renal artery stenosis. Br Med Bull. 2005;73-74:35-55.
Kwok-Mai M, Arend-Jand W, Gerjan N. Atherosclerotic renovascular disease and renal impairment: can we predict the effect of intervention?. Curr Hypertens Rep. 2007;9:140-147.
Levin A, Linas S, Friedrich L, Chapman A, Textor S. Controversies in renal artery stenosis: a review by the american society of nephrology advisory group on hypertension. Am J Nephrol. 2007;27:212-220.
Woolfson RG. Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis and intervention. Postgrad Med J. 2001;77: 68-74.
Kendrick J, Chonchol M. Renal artery stenosis and chronic ischemic nephropathy: Epidemiology and diagnosis. Adv Chronic Kidney Dis. 2008; 15 (4): 355- 362.
Cooper CJ, Murphy TP, Matsumoto A, Steffes M, Cohen Dj, Jaff M, et al. Stent revascularization for the prevention and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the coral trial. Am Heart J. 2006;152:59-66.
Van Jaarsveld BC, Krijnen P, Pieterman H, Perkx FH, Deinum J, Postma CT, et al. The effect on ballon angioplasty on hypertension in atherosclerotic renalartery stenosis. N Eng J Med. 2000;342:1007-1014.
Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? a meta-analisis of randomized controlled trials. Am J Med. 2003;114:44-50.